Sonoma Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Rule

AccesswireSep 19 08:30 ET

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance With Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution

AccesswireSep 17 08:30 ET

Express News | Sonoma Pharmaceuticals Has Been Granted FDA 510(k) Clearance For Its Microdacyn Wound Care Solution

BenzingaSep 16 15:36 ET

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

AccesswireSep 11 08:30 ET

Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending

BenzingaAug 29 19:50 ET

Sonoma Pharmaceuticals To Carry Out 1-for-20 Reverse Stock Split On August 30th, 2024

Moomoo NewsAug 28 19:35 ET